Striving Towards EmPowerment and Medication Adherence R01
A Randomized Control Trial of Striving Towards EmPowerment and Medication Adherence (STEP-AD)
University of Miami
250 participants
Aug 19, 2024
INTERVENTIONAL
Conditions
Summary
This is a study for Black women living with HIV to test a counseling program for Black women living with HIV. This participant may be a good fit if the participant is a Black woman, living with HIV, has a history of trauma, and is currently taking Antiretroviral Therapy (ART) medicines
Eligibility
Inclusion Criteria8
- Black
- Living with HIV
- Cis-gender female
- Age 18 or older
- English speaking
- Viral load non-suppression (\>200 ml) within the past year or a lack of HIV viral load measure for 6 consecutive months or more during the past 12 months
- History of trauma/abuse
- Capable of completing and fully understanding the informed consent process and study procedures
Exclusion Criteria2
- Unable to completely and fully understand the informed consent process and the study procedures
- Significantly interfering mental health symptoms (e.g., active psychosis that is untreated)
Interventions
This in-person STEP-AD intervention will consist of 10 sessions. Session 1: Life Steps Adherence Session 2: Psychoeducation on the treatment model Session 3: Substance Use and Enhancing Resilience Session 4: Trauma Impact Session 5: Cognitive Restructuring Session 6: Racial Discrimination Impact and Coping Session 7: HIV Stigma Impact and Coping Session 8: Gender-related Stressors and Coping Session 9: Body Image and Healthy Relationships Session 10: Practice, Review, and Relapse Prevention. Each session lasts for about 40 to 60 minutes.
Participants assigned to the E-TAU condition will receive 10 in person sessions to ensure comparable contact time with study staff and identical incentives. The first session will consist of a session on healthy living with HIV (CDC content on HIV 101 \[highlights importance of engaging in care, adhering to medication, finding support\], nutrition, and physical activity. The remaining 9 sessions will consist of neutral (daily events) writing. Women will be asked to write a description of their plans for the next 24 hours.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06463886